| Literature DB >> 23776588 |
Takeshi Shimamoto1, Nobutake Yamamichi, Shinya Kodashima, Yu Takahashi, Mitsuhiro Fujishiro, Masashi Oka, Toru Mitsushima, Kazuhiko Koike.
Abstract
Probably due to caffeine-induced gastric acid secretion, negative effects of coffee upon various upper-gastrointestinal diseases have been precariously accepted, despite the inadequate epidemiological evidence. Our aim is to evaluate the effect of coffee consumption on four major acid-related diseases: gastric ulcer (GU), duodenal ulcer (DU), reflux esophagitis (RE), and non-erosive reflux disease (NERD) based on the large-scale multivariate analysis. Of the 9,517 healthy adults, GU, DU, and RE were diagnosed by endoscopy, and NERD was diagnosed by the symptoms of heartburn and regurgitation without esophageal erosion. Associations between coffee consumption and the four disorders were evaluated, together with age, gender, body mass index (BMI), Helicobacter pylori (HP) infection status, pepsinogen I/II ratio, smoking, and alcohol. We further performed meta-analysis using the random effects model to redefine the relationship between coffee intake and peptic ulcer disease. The eligible 8,013 study subjects comprised of 5,451 coffee drinkers and 2,562 non-coffee drinkers. By univariate analysis, age, BMI, pepsinogen I/II ratio, smoking, and alcohol showed significant associations with coffee consumption. By multiple logistic regression analysis, positively correlated factors with significance were HP infection, current smoking, BMI, and pepsinogen I/II ratio for GU; HP infection, pepsinogen I/II ratio, and current smoking for DU; HP non-infection, male, BMI, pepsinogen I/II ratio, smoking, age, and alcohol for RE; younger age, smoking, and female for NERD. The meta-analyses could detect any association of coffee consumption with neither GU nor DU. In conclusion, there are no significant relationship between coffee consumption and the four major acid-related upper gastrointestinal disorders.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23776588 PMCID: PMC3680393 DOI: 10.1371/journal.pone.0065996
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Study recruitment flowchart.
Of the 9,517 healthy adults, we excluded subjects with prior gastric surgery (111), taking PPIs and/or H2RAs (493), and having history of Helicobacter pylori eradication (900). Among the eligible 8,013 subjects, numbers of subjects with GU, DU, RE, NERD, and other subjects free from the four major upper gastrointestinal disorders are shown.
Figure 2A venn diagram showing numbers of the four acid-related upper gastrointestinal disorders in our cohort.
Characteristics of the study population and univariate analysis of risk factors for coffee.
| Drinker | Non-drinker | |||
| N = 5,451 | N = 2,562 | |||
| N (%) | N (%) |
| ||
|
| ||||
|
| 626 (67.6) | 300 (32.4) | <0.001 |
|
|
| 1,937 (72.7) | 727 (27.3) | ||
|
| 2,265 (69.0) | 1,017 (31.0) | ||
|
| 583 (57.1) | 438 (42.9) | ||
|
| 40 (33.3) | 80 (66.7) | ||
|
| 49.8 (±8.2) | 51.5 (±9.7) | <0.001 |
|
|
| ||||
|
| 3,194 (67.5) | 1,476 (32.5) | 0.405 |
|
|
| 2,257 (67.5) | 1,086 (32.5) | ||
|
| ||||
|
| 302 (63.7) | 172 (36.3) | 0.020 |
|
|
| 3,921 (68.9) | 1,772 (31.1) | ||
|
| 1,228 (66.6) | 618 (33.4) | ||
|
| 22.9 (±3.2) | 23.1 (±3.5) | 0.059 |
|
|
| ||||
|
| 312 (62.3) | 189 (37.7) | 0.003 |
|
|
| 588 (65.8) | 306 (34.2) | ||
|
| 4,553 (68.8) | 2,065 (31.2) | ||
|
| 5.4 (±2.0) | 5.2 (±2.1) | 0.007 |
|
|
| ||||
|
| 2,695 (64.4) | 1,487 (35.6) | <0.001 |
|
|
| 1,567 (67.8) | 744 (32.2) | ||
|
| 1,189 (78.2) | 331 (21.8) | ||
|
| ||||
|
| 2,028 (65.2) | 1,081 (34.8) | <0.001 |
|
|
| 3,423 (69.8) | 1,481 (30.2) | ||
|
| ||||
|
| 1,681 (67.1) | 823 (32.9) | 0.247 |
|
|
| 3,770 (68.4) | 1,739 (31.6) |
A p-value less than 0.05 was considered statistically significant.
Pearson's chi-square test;
Welch's t test;
Student's t-test.
The presence or absence of disorders with coffee consumption (in cups/day).
| without disorders | Gastric ulcer | Duodenal ulcer | Reflux esophagitis | Non-erosive reflux disease | ||||||
| Coffee consumption per day | No of subjects | N (%) |
| N (%) |
| N (%) |
| N (%) |
| N (%) |
| <1/day | 2,562 | 1,848 (31.6) | 0.229 | 14 (32.6) | 0.093 | 12 (37.5) | 0.360 | 339 (34.1) | 0.174 | 358 (32.0) |
| 1–2/day | 2,978 | 2,206 (37.7) | 10 (23.2) | 8 (25.0) | 345 (34.7) | 414 (37.0) | ||||
| ≥3/day | 2,473 | 1,795 (30.7) | 19 (44.2) | 12 (37.5) | 310 (31.2) | 346 (31.0) | ||||
| Total | 8,013 | 5,849 | 43 | 32 | 994 | 1,118 |
Include overlapping disorders of Gastric ulcer, Duodenal ulcer, Reflux esophagitis and Non-erosive reflux disease.
Cochran–Armitage test for trend.
Summary of the estimate of Peptic Ulcer Diseases in multiple logistic regression analysis.
| Gastric ulcer (N = 8,013) | Duodenal ulcer (N = 8,013) | |||||
| Standardized Coefficient | Odds Ratio (95% CI) |
| Standardized Coefficient | Odds Ratio (95% CI) |
| |
|
| 0.173 | 1.04 (0.99–1.08) | 0.066 | −0.024 | 1.00 (0.95–1.04) | 0.811 |
|
| ||||||
|
| reference | reference | ||||
|
| −0.031 | 0.89 (0.40–2.14) | 0.780 | 0.152 | 1.75 (0.65–5.23) | 0.252 |
|
| 0.253 | 1.15 (1.06–1.24) | <0.001 | −0.101 | 0.95 (0.83–1.06) | 0.332 |
|
| 0.248 | 1.24 (1.01–1.50) | 0.022 | 0.420 | 1.45 (1.17–1.74) | <0.001 |
|
| ||||||
|
| reference | reference | ||||
|
| 0.187 | 2.12 (0.89–5.31) | 0.083 | −0.053 | 0.81 (0.28–2.26) | 0.669 |
|
| 0.275 | 3.57 (1.49–8.98) | 0.003 | 0.184 | 2.35 (0.98–5.94) | 0.048 |
|
| ||||||
|
| reference | reference | ||||
|
| −0.018 | 0.94 (0.48–1.90) | 0.841 | 0.016 | 1.03 (0.79–1.37) | 0.336 |
|
| ||||||
|
| reference | reference | ||||
|
| −0.104 | 0.68 (0.29–1.52) | 0.329 | −0.166 | 0.54 (0.21–1.28) | 0.145 |
|
| 0.059 | 1.26 (0.62–2.61) | 0.505 | −0.059 | 0.79 (0.35–1.80) | 0.557 |
|
| ||||||
|
| reference | reference | ||||
|
| 0.746 | 18.55 (6.89–53.72) | <0.001 | 0.924 | 37.23 (12.39–127.30) | <0.001 |
: A p-value less than 0.05 was considered statistically significant.
Summary of the estimate of GERD syndrome in multiple logistic regression analysis.
| Reflux esophagitis (N = 6,895) | Non-erosive reflux disease (N = 7,019) | |||||
| Standardized Coefficient | Odds Ratio (95% CI) |
| Standardized Coefficient | Odds Ratio (95% CI) |
| |
|
| 0.159 | 1.02 (1.01–1.03) | <0.001 | −0.154 | 0.98 (0.97–0.99) | <0.001 |
|
| ||||||
|
| reference | reference | ||||
|
| 0.426 | 2.37 (1.95–2.90) | <0.001 | −0.125 | 0.78 (0.66–0.91) | 0.002 |
|
| 0.399 | 1.13 (1.11–1.15) | <0.001 | 0.073 | 1.02 (1.00–1.04) | 0.035 |
|
| 0.220 | 1.11 (1.06–1.17) | <0.001 | −0.031 | 0.99 (0.94–1.03) | 0.521 |
|
| ||||||
|
| reference | reference | ||||
|
| 0.109 | 1.24 (1.04–1.49) | 0.019 | 0.086 | 1.19 (0.63–1.32) | 0.048 |
|
| 0.214 | 1.62 (1.33–1.98) | <0.001 | 0.139 | 1.36 (1.12–1.64) | 0.002 |
|
| ||||||
|
| reference | reference | ||||
|
| 0.143 | 1.34 (1.14–1.58) | <0.001 | 0.059 | 1.13 (0.98–1.30) | 0.093 |
|
| ||||||
|
| reference | reference | ||||
|
| −0.062 | 0.88 (0.74–1.04) | 0.133 | −0.036 | 0.93 (0.79–1.08) | 0.336 |
|
| −0.081 | 0.84 (0.70–1.01) | 0.057 | −0.032 | 0.93 (0.79–1.10) | 0.408 |
|
| ||||||
|
| reference | reference | ||||
|
| −0.482 | 0.35 (0.28–0.45) | <0.001 | 0.065 | 1.15 (0.94–1.40) | 0.158 |
: A p-value less than 0.05 was considered statistically significant.
Figure 3Forest plots of the odds ratios and 95% confidential intervals for upper gastrointestinal peptic ulcer.
Forest plots of the odds ratios and 95% confidential intervals for gastric ulcer (A), duodenal ulcer (B), and peptic ulcer (C) relating coffee intake. The gray box represents the odds ratio estimates in each study, and the horizontal line indicates the 95% confidential intervals for each study. Diamonds at the bottom represent the pooled odds ratio estimates. Weights are from random effect meta-analysis.